Special Issue "Vaccination in Patients with Autoimmune Diseases"

A special issue of Vaccines (ISSN 2076-393X).

Deadline for manuscript submissions: closed (28 February 2023) | Viewed by 89

Special Issue Editor

Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea
Interests: vaccination in patients with rheumatic diseases; vasculitis; vasculopathy

Special Issue Information

Dear Colleagues, 

The ongoing COVID-19 pandemic has demonstrated the importance and efficacy of vaccination in preventing the deadly disease, not only in the general population but also in patients with autoimmune rheumatic diseases who are at higher risk of severe infection or death from a preventable infection. 

To achieve a more extensive understanding of recent scientific knowledge and current trends in vaccination in patients with autoimmune diseases, this Special issue aims to focus on (i) the efficacy and safety of vaccines, (ii) humoral and cellular immune response to vaccines in light of immunomodulatory treatment, (iii) the distribution and uptake of vaccines, and (iv) novel vaccination strategies to improve vaccine response in patients with autoimmune diseases.

Dr. Jin Kyun Park
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • vaccination
  • efficacy and safety
  • autoimmune disease, rheumatic diseases
  • immune response to vaccines
  • novel vaccination strategies

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop